A Phase 1 Study to Evaluate the Effect of Food on the LY3537982 Pharmacokinetics in Health Adult Subjects
Latest Information Update: 03 Oct 2023
At a glance
- Drugs Olomorasib (Primary)
- Indications Non-small cell lung cancer; Solid tumours
- Focus Pharmacokinetics
- Sponsors Eli Lilly and Company
- 28 Sep 2023 Status changed from recruiting to completed.
- 01 Jun 2023 Status changed from not yet recruiting to recruiting.
- 26 Apr 2023 New trial record